David A. Fisher, MD, director, Total Joint Center, Indiana Orthopaedic Hospital discusses which patients qualify as candidates for total knee replacement surgery. According to Fisher, progressive loss of function that impacts…
David A. Fisher, MD, director, Total Joint Center, Indiana Orthopaedic Hospital talks about the symptoms and treatments of osteoarthritis in the knee. Common symptoms include aching with activity,…
NEW YORK (Reuters Health) – Vitamin D, especially in combination with calcium, may reduce the risk of falls, according to a report in the July 27th online issue…
NEW YORK (Reuters Health) – Patients with arthritis acknowledge having thoughts of suicide twice as often as people without arthritis, researchers report. “Suicidal ideation is prevalent among adults…
Join us for our Abstract Highlights – AACE 2011 Conference – Long Term Effects of Denosumab in Postmenopausal Osteoporosis. Participants in the 2011 AACE annual meeting considered a…
NEW YORK (Reuters Health) – A single dose of zoledronate prevents bone loss associated with glucocorticoid therapy given for acute exacerbation of Crohn’s disease, a German team reports…
NEW YORK (Reuters Health) – Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
